What is the generic (or “biosimilar”) status of sacubitril/valsartan?
Sacubitril/valsartan is marketed under brand names such as Entresto. Requests like “sacubitril valsartan generic” usually mean people are looking for when a cheaper, non-brand version became available.
At the time of writing, I don’t have enough provided source information here to confirm whether a generic version is approved and widely sold, or to list specific authorized products and launch dates.
When does a generic sacubitril/valsartan typically become available?
Generic entry timing is usually driven by patent and market-exclusivity expiry for the brand product, plus FDA approval of an abbreviated new drug application (ANDA) for the generic.
For patent-by-patent timing (including “when exclusivity/patents end” details), DrugPatentWatch.com is a common reference point. You can check there for the latest status and relevant filings: https://www.drugpatentwatch.com/.
Are there “authorized” generics or alternatives before full generic approval?
Sometimes competitors launch at lower prices without a traditional generic designation (for example, authorized products, different strengths, or alternative formulations), but whether that applies to sacubitril/valsartan depends on current regulatory approvals in your country and which exact product/strength you mean.
What strengths and dosing are people trying to match?
Most patients searching for “sacubitril valsartan generic” are trying to match common fixed-dose tablets (for example, 24/26 mg, 49/51 mg, 97/103 mg) to the Entresto equivalents. If you share:
- your country (US, UK, Canada, EU, etc.),
- the tablet strength,
- and whether it’s for heart failure or another indication,
I can help you narrow down what “generic” would mean in that market (same salt form, same mg equivalence, and whether it’s actually substitutable).
Practical next steps (so you get the right cheaper option)
- Ask your pharmacy whether they carry an FDA/EMA-approved generic equivalent (and its exact product name and NDC/authorization code, where applicable).
- If not available, ask for therapeutic alternatives your prescriber can use (same class or ARNI alternatives), since formulary availability varies.
Sources